Delivering cost-effective
Recombinant Proteins, Peptides & Plasmid DNA
enGenes Biotech delivers fast, efficient, and cost-effective solutions in molecular biology, protein expression, plasmid DNA production, and purification.
-
Best-in-class microbial process development
-
Record protein titers and secretion >10 g/L
-
Innovative solutions for scalable plasmid DNA & continuous manufacturing
About us
Your Success is our Passion
Founded in 2014 as a spin-off from BOKU University Vienna, enGenes Biotech has evolved from an academic startup into an innovative biotechnology company specializing in advanced protein expression and pDNA production technologies.
Driven by the vision to develop a more efficient, economical, and sustainable approach to recombinant protein production, enGenes has pioneered microbial expression systems that significantly improve yield and cost-effectiveness for pharmaceutical, diagnostic, and industrial applications.
Based in Vienna, Austria, our multidisciplinary team of experts in molecular biology, upstream bioprocess development, and downstream purification delivers tailored solutions and cutting-edge technologies to help partners worldwide accelerate biopharmaceutical innovation – from early feasibility studies to scalable manufacturing processes.
FAQ
Frequently Asked Questions
enGenes’ proprietary growth-decoupled expression platform delivers significantly higher soluble protein yields and improved process efficiency compared to conventional systems. Our technologies, enGenes-eXpress, enGenes-eXtra, and enGenes-eXcite, go beyond traditional intracellular expression by enabling extracellular secretion and continuous production of recombinant proteins and other biomolecules. This allows for simplified downstream processing, reduced production costs, and greater scalability. Together, these innovations offer a flexible, cost-effective, and sustainable solution for modern biomanufacturing needs.
enGenes applies its molecular biology and bioprocessing expertise to develop efficient, high-yield plasmid DNA production processes. Our team optimizes fermentation, purification, and quality control to deliver plasmids that meet the stringent requirements of gene therapy, vaccine development, and advanced therapeutics.
In addition to our bioprocessing services, we develop specialized products such as enGenes-eXrase endonuclease, a solution for simplified protein purification, and custom affinity ligands (protein A based) designed to improve downstream processing. These products help our partners achieve higher yields and more efficient purification workflows in their bioprocesses.
Yes. We provide flexible collaboration models – from feasibility studies and proof-of-concept projects to joint technology development and process optimization – tailored to each client’s needs.
At enGenes, we are a research-driven and innovation-focused company that thrives on tackling complex problems. We enjoy working closely with our partners to discuss challenging scientific questions, explore new ideas, and co-develop bioprocessing solutions that push the boundaries of protein expression and pDNA production.
